Skip to content
healthcare.dev

RIVASTIGMINE TARTRATE

NDC 33342-091, RIVASTIGMINE TARTRATE, capsule, from Macleods Pharmaceuticals Limited.

Product NDC
33342-091
Status
Listed
Labeler
Macleods Pharmaceuticals Limited
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203148
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/33342-091 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVASTIGMINE TARTRATE4.5 mg/1

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
33342-091-06333420091063 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-091-06) / 10 CAPSULE in 1 BLISTER PACK
33342-091-093334200910960 CAPSULE in 1 BOTTLE (33342-091-09)
33342-091-123334200911210 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-091-12) / 10 CAPSULE in 1 BLISTER PACK
33342-091-1533342009115500 CAPSULE in 1 BOTTLE (33342-091-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4364f6ef-a8da-4805-be0d-aabbe8ca2d21
  • NADAC price for package 33342009109

    GET /v1/drugs/nadac/33342009109
  • NADAC price for package 33342009115

    GET /v1/drugs/nadac/33342009115

Use it

Look up 33342-091 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/33342-091 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 33342-091. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.